Dusseux Eric Michel 4
4 · Bionik Laboratories Corp. · Filed Jul 30, 2019
Insider Transaction Report
Form 4
Dusseux Eric Michel
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-07-26+115,759→ 115,759 totalExercise: $3.59Exp: 2026-07-26→ Common Stock, par value $0.001 (115,759 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable as follows: (i) 19,293 shares on each of September 1, 2019, September 1, 2020 and September 1, 2021; and (ii) 19,293 shares on September 1, 2019, 19,293 shares on September 1, 2020, and 19,294 shares on September 1, 2021 based on Dr. Dusseux's achievement of annual performance goals to be established by the Compensation Committee of the Board of Directors in consultation with Dr. Dusseux. The extent to which each separate performance tranche becomes vested shall be determined by reference to the performance targets set for that performance period.